Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04415879
Other study ID # 20-538
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date June 1, 2020
Est. completion date August 1, 2020

Study information

Verified date August 2020
Source The Cleveland Clinic
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study intends to find out how a cloth mask may impact exercise capacity, to provide guidance for exercisers to adjust their expectations and training accordingly. The investigators plan to asses exercise capacity through estimated peak oxygen consumption (eVO2peak), oxygen saturation and level of perceived exertion during treadmill based exercise while wearing a cloth mask compared to exercising without a cloth mask. The potential significance of this study is to determine if subjects can exercise safely and if their exercise training needs to be adjusted while following the current recommendations of wearing a cloth mask in public. The degree of airflow limitation experienced will depend on the type and fit of the mask being worn, and inadequeate airflow could possibly result in CO2 re-breathing if all air was not fully discharged from the mask with each breath. This re-breathing of CO2 could potentially limit the workload leading to a detriment in performance, and increase in adverse symptoms such as dizziness, lightheadedness, chest pain or shortness of breath that does not improve with rest.


Description:

If healthcare providers are going to recommend that individuals exercise with cloth masks, it is imperative that future research is conducted to evaluate the degree to which airflow can be limited during exercise by wearing a cloth mask. At the completion of the study, the investigators will have further understanding of the effects of face masks during treadmill based running. To the investigators knowledge this is the first study to assess the effects of wearing protective cloth mask on exercise capacity.

Hypothesis The null hypothesis HO states that exercising with a cloth mask will be inferior to the current standard of exercising without a facemask, limiting peak exercise when non-inferiority margin is 1 estimated metabolic equivalent ( eMET 3.5 mlO2*kg-1*min-1).

The alternative hypothesis H1 states that exercising with a mask will not be inferior to the current standard of exercising without a facemask, limiting peak exercise when non-inferiority margin is 1 eMET.

EXPERIMENTAL DESIGN & METHODS Subject Recruitment: The investigators will recruit 20 subjects though the Cleveland Clinic. Inclusion Criteria: Healthy subjects age > 18, Exclusion Criteria: Any long-term disease that would interfere with their ability to exercise safely, fever >100.4 F, or pregnancy. Informed consent will be obtained by the CoPI, and need for medical clearance determined based on ACSM's 2015 preparticipation guidelines. To remain compliant with enterprise guidelines we will not be recruiting healthy subjects outside of the Cleveland Clinic staff at this time to avoid increase COVID-19 exposure risk. However, if the enterprise changes the guidelines we will expand our enrollment to include non Cleveland Clinic employees. Employees will not be solicited by direct initiation. Recruitment will involve only posted notice or general advertising that does not pressure employees into participating for fear of job loss, delayed promotion, or other influences from their superior.

Study Design: The study design is a prospective crossover non-inferiority trial where subjects will complete 3 separate graded exercise treadmill tests each time wearing either No Mask, N-95 Mask (3M), or Cloth Mask (Boco). The order of the mask worn will be randomly assign to minimize familiarization or training effect. All testing will be performed in a Cleveland Clinic facility following standardized COVID-19 screening precautions. The investigators will compare the data collected from each test to asses for differences between subject comfort, peak exercise capacity (eMET), heart rate response during exercise and recovery.

Testing: After completing the informed consent and being medically cleared, subjects will then perform a symptom limited graded exercise treadmill test using a modified Balke protocol with continuous 12-lead EKG monitoring. Exercise tests will be stopped if any significant cardiac arrhythmias occur or significant ST segment depressions develops. The test will be terminated if ST elevation (> 1.0 mm), marked ST displacement (horizontal or downsloping of > 2mm, measured 60 to 80 ms after the J point), moderate to severe angina, Signs of poor perfusion (cyanosis or pallor), Sustained ventricular tachycardia or other arrhythmia, including second or third decree AV block, that interferes with normal maintenance of cardiac output during exercise, or development of bunle-branch block that cnannot be distinguished from bentricular tachycardia. The modified Balke, which is a well-accepted treadmill protocol that keeps the speed constant and increases workload by grade. Subjects will rest for 3 minutes and resting heart rate, blood pressure, subjective perceptions of the face mask will be measured. Subjects then will walk at 0% grade at 3 miles per hour for 2 minutes. Elevation will be increased by 2% after the initial 2 minutes and by 1% each minute thereafter until the test is terminated. Heart rate, RPEand oxygen saturation will be measured with a pulse oximeter at baseline, last 5-10 seconds of each stage and the investigators will continue to monitor heart rate during recovery at 1, 3 and 5 minutes post exercise. The investigators will monitor each stage for perceived exertion, feelings of light headedness, anxiety, and discomfort. The test will also be terminated at the request of the subject or if any chest pain develops. The scale of measuring subjective perceptions instrument will be adminstereted after collecting 5 minutes of resting, end of the exercise test, and at 5 minutes post recovery. The graded exercise test will be performed once with No Mask, once with a 3M 8200 N-95 Respirator, and once with a Cloth Mask (Boco). Subjects will be randomized by a random number generater (1= No Mask, 2= N-95, 3= Cloth Mask) to determine the order the perform each exercise test No Mask, N-95 or Cloth Mask and will complete the other tests 2 atleast 1 day apart. Subjects will be instructed to abstain from exercise for 2 days before the test.

Mask:

3M 8200 N-95 Respirator obtain from a third party provider. N-95 Respirators have been purchased outside the Cleveland Clinic supply chain. Cloth Face Mask manufactured by Boco is a custom designed two-layer face masks are built with a tightly woven polyester outer shell fabric and a soft, breathable performance knit mesh inner linig. Includes a slit pocket where a filter can be added.


Recruitment information / eligibility

Status Completed
Enrollment 20
Est. completion date August 1, 2020
Est. primary completion date August 1, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Age 18 years or older

- Cleveland Clinic Employee

- Must not be pregnant

Exclusion Criteria:

- Medical condition that would interfere with ability to exercise safely

Study Design


Related Conditions & MeSH terms


Intervention

Device:
N-95 Respirator
N-95 mask will be worn as personal protective equipment during a graded exercise test
Cloth Face Mask
A cloth mask will be worn as personal protective equipment during a graded exercise test
Diagnostic Test:
Graded exercise test
No personal protective equipment during a graded exercise test

Locations

Country Name City State
United States Cleveland Clinic Cleveland Ohio

Sponsors (1)

Lead Sponsor Collaborator
The Cleveland Clinic

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Exercise Capacity To gain further understanding on effects exercising with a cloth mask has on exercise capacity. Our working hypothesis is that wearing a face mask will limit exercise capacity by a minimal clinically important difference (MCID) of 1 estimated Metabolic Equivalent (eMET 3.5 O2 ml/kg/min). 4 Weeks
See also
  Status Clinical Trial Phase
Withdrawn NCT06065033 - Exercise Interventions in Post-acute Sequelae of Covid-19 N/A
Completed NCT06267534 - Mindfulness-based Mobile Applications Program N/A
Completed NCT05047601 - A Study of a Potential Oral Treatment to Prevent COVID-19 in Adults Who Are Exposed to Household Member(s) With a Confirmed Symptomatic COVID-19 Infection Phase 2/Phase 3
Recruiting NCT04481633 - Efficacy of Pre-exposure Treatment With Hydroxy-Chloroquine on the Risk and Severity of COVID-19 Infection N/A
Recruiting NCT05323760 - Functional Capacity in Patients Post Mild COVID-19 N/A
Completed NCT04537949 - A Trial Investigating the Safety and Effects of One BNT162 Vaccine Against COVID-19 in Healthy Adults Phase 1/Phase 2
Completed NCT04612972 - Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) to Prevent COVID-19 in Healthy Adult Population In Peru Healthy Adult Population In Peru Phase 3
Recruiting NCT05494424 - Cognitive Rehabilitation in Post-COVID-19 Condition N/A
Active, not recruiting NCT06039449 - A Study to Investigate the Prevention of COVID-19 withVYD222 in Adults With Immune Compromise and in Participants Aged 12 Years or Older Who Are at Risk of Exposure to SARS-CoV-2 Phase 3
Enrolling by invitation NCT05589376 - You and Me Healthy
Completed NCT05158816 - Extracorporal Membrane Oxygenation for Critically Ill Patients With COVID-19
Recruiting NCT04341506 - Non-contact ECG Sensor System for COVID19
Completed NCT04512079 - FREEDOM COVID-19 Anticoagulation Strategy Phase 4
Completed NCT04384445 - Zofin (Organicell Flow) for Patients With COVID-19 Phase 1/Phase 2
Completed NCT05975060 - A Study to Evaluate the Safety and Immunogenicity of an (Omicron Subvariant) COVID-19 Vaccine Booster Dose in Previously Vaccinated Participants and Unvaccinated Participants. Phase 2/Phase 3
Active, not recruiting NCT05542862 - Booster Study of SpikoGen COVID-19 Vaccine Phase 3
Withdrawn NCT05621967 - Phonation Therapy to Improve Symptoms and Lung Physiology in Patients Referred for Pulmonary Rehabilitation N/A
Terminated NCT05487040 - A Study to Measure the Amount of Study Medicine in Blood in Adult Participants With COVID-19 and Severe Kidney Disease Phase 1
Terminated NCT04498273 - COVID-19 Positive Outpatient Thrombosis Prevention in Adults Aged 40-80 Phase 3
Active, not recruiting NCT06033560 - The Effect of Non-invasive Respiratory Support on Outcome and Its Risks in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2)-Related Hypoxemic Respiratory Failure